(Q38435156)

3 September 2017

Neuropsychological performance in medicated vs. unmedicated patients with obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

3 September 2017

1 reference

1 reference

Josep Pifarré

3

0 references

Pino Alonso

object named as

Pino Alonso

2

0 references

David Mataix-Cols

object named as

David Mataix-Cols

1

0 references

author name string

Josep Manuel Menchón

4

1 reference

PubMed ID

11959362

3 September 2017

Julio Vallejo

5

1 reference

PubMed ID

11959362

3 September 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

3 September 2017

1 reference

3 September 2017

109

1 reference

3 September 2017

3

1 reference

3 September 2017

255-264

1 reference

The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Fluoxetine-induced memory impairment in an adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Memory effects of clomipramine treatment: Relationship to CSF monoamine metabolites and drug concentrations in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Fluoxetine and memory impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Neuropsychological performance in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

The effects of diazepam and oxprenolol on short term memory in individuals of high and low state anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Deficit in cognitive shifting ability in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Working memory as assessed by subject-ordered tasks in patients with obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Reduced design fluency in subclinical obsessive-compulsive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Cognitive dysfunction associated with fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

The effects on performance of two antidepressants, alone and in combination with diazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Obsessive compulsive disorder and basal ganglia dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

Strategic processing and episodic memory impairment in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900024-0

7 January 2021

10.1016/S0165-1781(02)00024-0

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

11959362